-1366x0.jpg)
The 2023 Vietnam-France Obstetrics and Gynecology Conference was a highly esteemed and eagerly anticipated annual scientific event organized by the National Hospital of Obstetrics and Gynecology. The conference served as a platform for domestic and international experts to convene, share clinical and paraclinical experiences, as well as keep abreast of the latest advancements in the fields of obstetrics, gynecology, neonatology, assisted reproductive technology, fetal medicine, pharmaceuticals, and more.
Nguyen Viet Quang, M.D, M.Sc., presented a report on "The Significance of Non-Invasive Prenatal Testing (NIPT) in Multiple Pregnancy Management"
The conference program included 1 plenary session, 8 specialized thematic sessions, featuring the presentation and discussion of 55 scientific papers, as well as 4 side workshops addressing the most topical issues in the domains of obstetrics and gynecology, assisted reproductive technology, endocrinology, neonatology, pharmaceuticals, and more. The event drew the participation of thousands of professors, physicians, and experts from leading hospitals across Vietnam as well as countries with renowned healthcare systems globally.
GENTIS was proud to serve as a Silver Sponsor of the 2023 Vietnam-France Obstetrics and Gynecology Conference, and had organized numerous engaging side activities. Notably, GENTIS's exhibition booth showcasing the products had received substantial interest from the large number of attendees and delegates. Leading experts in the fields of obstetrics, gynecology, and assisted reproductive technologies had expressed high praise for GENTIS's genetic testing solutions, especially PGTest, FSH receptor gene polymorphisms, NIPT GenEva, and newborn screening, etc.
In addition to the genetic testing consultation activities, the GENTIS exhibition booth also organized a variety of games and a lucky draw program, with a 100% chance of winning prizes for the distinguished delegates and physicians in attendance… Through the introduction of the genetic testing services at the conference, GENTIS hopes to continue collaborating with esteemed physicians/ clinics/ hospitals/ IVF centers in bringing cutting-edge genetic tests closer to expectant mothers in Vietnam.
Many lucky guests received meaningful gifts from GENTIS
Particularly, GENTIS was honored to collaborate with scientific presentations delivered by leading experts in the fields of assisted reproductive technologies and pediatrics:
- "Poor Ovarian Response" by Assoc. Prof. Ho Sy Hung, PhD. (Deputy Director, National Assisted Reproductive Technology Center)
- "The Significance of Non-Invasive Prenatal Testing (NIPT) in Multiple Pregnancy Management" by Nguyen Viet Quang, M.D, M.Sc. (Director, National Assisted Reproductive Technology Center - National Hospital of Obstetrics and Gynecology)
- "Newborn Screening for Hemoglobin Disorders" by Tran Thi Chi Mai, PhD. (Head of Biochemistry Department, National Children's Hospital - Hanoi Medical University)
Assoc. Prof. Ho Sy Hung, PhD. (Deputy Director, National Assisted Reproductive Technology Center) presented the scientific report "Poor Ovarian Response and FSH Receptor Gene Polymorphisms"
The three specialized and in-depth presentations delivered by leading experts clearly affirmed the "backbone" role of genetic testing in the diagnosis and treatment of diseases within the domains of assisted reproduction, obstetrics, and pediatrics. Moreover, these research papers also received widespread positive feedback from both domestic and international physicians, specialists, and scientists. The distinguished delegates unanimously concurred that these were highly practically-oriented presentations that accurately and promptly reflected the current needs in the fields of assisted reproduction, obstetrics, and pediatrics in Vietnam.
Tran Thi Chi Mai, PhD. (Head of Biochemistry Department, National Children's Hospital) and Ms. Dam Anh Ngoc (Representative, GENTIS)
Participating in the 2023 Vietnam-France Obstetrics and Gynecology Conference was also one of the activities that demonstrated GENTIS' efforts to bring high-quality, safe, and effective genetic testing products to the market, further contributing positively to the responsibility for community health and advancing the practice of humane and progressive medicine.
With the comprehensive genetic testing ecosystem, GENTIS is poised to capably fulfill the requirements of medical professionals specializing in assisted reproductive technologies, obstetrics, gynecology, and pediatrics. In this regard, the company aims to contribute efforts towards the progressed development of diagnostic testing and treatment modalities within the domains of assisted reproduction, obstetrics, gynecology, and pediatrics in Vietnam.
